AbbVie completes $10.9 billion Apogee acquisition
AbbVie completed its $10.9 billion acquisition of Apogee Therapeutics and reaffirmed 2026 adjusted diluted EPS guidance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AbbVie completes acquisition of Apogee Therapeutics
AbbVie completed its acquisition of Apogee Therapeutics.